Summary of GPIIIa peptides eliciting PBMC proliferation from disease control donors in vitro
| Patient control . | Sex . | Age at testing, y . | Clinical disease . | Platelet count at testing, × 109/L . | Stimulatory peptides, SI > 3 . |
|---|---|---|---|---|---|
| C26 | M | 54 | Aplastic anemia | 4 | None |
| C27 | M | 56 | Aplastic anemia | 49 | None |
| C28 | M | 64 | Aplastic anemia | 3 | None |
| C29 | M | 24 | Aplastic anemia | 4 | 14 |
| C30 | F | 69 | Aplastic anemia | 23 | 82* |
| Patient control . | Sex . | Age at testing, y . | Clinical disease . | Platelet count at testing, × 109/L . | Stimulatory peptides, SI > 3 . |
|---|---|---|---|---|---|
| C26 | M | 54 | Aplastic anemia | 4 | None |
| C27 | M | 56 | Aplastic anemia | 49 | None |
| C28 | M | 64 | Aplastic anemia | 3 | None |
| C29 | M | 24 | Aplastic anemia | 4 | 14 |
| C30 | F | 69 | Aplastic anemia | 23 | 82* |
Immunodominant peptides.